AVENSYS UK LTD

• ◆

  3 officer resignations in last 12 months

  Multiple officers have left the board recently — see the People section for who.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +12.3%

  £17,034,690 → £19,126,402

• Cash

  +77.6%

  £968,900 → £1,720,888

• Net assets

  +8.3%

  £4,779,010 → £5,176,403

• Employees

  +0.6%

  175 → 176

• Operating profit

  +599.9%

  £76,798 → £537,515

• Profit before tax

  +419.5%

  £110,248 → £572,783

• Wages

  +5%

  £5,552,035 → £5,827,417

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

MHA Audit Services LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“These financial statements have been prepared on a going concern basis on the grounds that the directors consider that the company has sufficient cash resources to enable the company to continue to meet its liabilities as they fall due.”

Significant events

• “Employee engagement: Paused in 2024 due to restructuring process in the VAMED group.”
• “The performance of the company during 2024 showed a sustainable return to profitability in the business units, foremost by providing fully-comp endoscopy repair services to sister companies in Germany.”
• “The global increase in fuel prices for gas, electricity and motor fuel has led to both increased supplier and salary costs. Our import and export costs have increased since the UK left the EU. This has had an impact on profitability since these costs were not passed on to our customer base.”
• “Since the announcement in May 2024 that Fresenius SE & Co KGaA intends to take over the technical services business segment from VAMED AG, of which the Avensys UK Group Limited including Avensys UK Ltd as a 100% subsidiary is the main core business, this step was legally executed as of January 1, 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

9

last 12 months

Capital events

0

last 24 months

Officers appointed

2

last 12 months

Officers resigned

3

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.